Yuko Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuko Nakamura has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Hitoshi Matsumoto
2 shared publicationsAkiko Yasuda
Food and Health R&D Laboratories, Meiji Seika Kaisha, Ltd., Saitama, Japan
1 shared publicationHiroyuki Iida
1 shared publication- Hitoshi Matsumoto
Bioscience Laboratories, Meiji Seika Kaisha, Ltd., 5-3-1 Chiyoda, Sakado-shi, Saitama 350-0289, Japan
1 shared publication - Jinichiro Koga
Faculty of Science and Engineering, Teikyo University Department of Integrated Science and Engineering Utsunomiya, Tochigi
1 shared publication Kazuo Todoki
Department of Pharmacology, Kanagawa Dental College
1 shared publication
Latest Publications
- 14 June 2011
- Published by Wiley in BioFactors
- Vol. 43 (2) , 145-151
Fructooligosaccharides suppress high‐fat diet‐induced fat accumulation in C57BL/6J mice
Two experiments were performed to examine the effects of fructooligosaccharides (FOS) on the development of obesity. In the first experiment, Wistar rats were orally administered a 2.5 g/kg body weight lipid emulsion containing FOS, and the subsequent elevation of plasma triglycerides was significantly suppressed compared with that in rats receiving lipid emulsion alone. In the second experiment, C57BL/6J male mice were fed a high‐fat “western” diet with or without 2.5% FOS supplementation (n= 10/group)ad libitumfor 12 weeks. Body weight and percent body fat were lower in mice fed FOS than in controls. Furthermore, the weight of the visceral adipose tissue, and the weight and triglyceride content of the liver were significantly lower in the high‐fat + FOS group. Fecal excretion of lipids was markedly enhanced by FOS consumption. These results indicate that dietary FOS suppress high‐fat diet‐induced body fat accumulation, and inhibit intestinal absorption of dietary fat.
- 14 June 2011
- Published by Wiley in BioFactors
- Vol. 43 (2) , 145-151
Fructooligosaccharides suppress high‐fat diet‐induced fat accumulation in C57BL/6J mice
Two experiments were performed to examine the effects of fructooligosaccharides (FOS) on the development of obesity. In the first experiment, Wistar rats were orally administered a 2.5 g/kg body weight lipid emulsion containing FOS, and the subsequent elevation of plasma triglycerides was significantly suppressed compared with that in rats receiving lipid emulsion alone. In the second experiment, C57BL/6J male mice were fed a high‐fat “western” diet with or without 2.5% FOS supplementation (n= 10/group)ad libitumfor 12 weeks. Body weight and percent body fat were lower in mice fed FOS than in controls. Furthermore, the weight of the visceral adipose tissue, and the weight and triglyceride content of the liver were significantly lower in the high‐fat + FOS group. Fecal excretion of lipids was markedly enhanced by FOS consumption. These results indicate that dietary FOS suppress high‐fat diet‐induced body fat accumulation, and inhibit intestinal absorption of dietary fat.
- 27 January 2010
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 58 (2) , 1174-1179
Development and Validation of a Liquid Chromatography Tandem Mass Spectrometry Method for Simultaneous Determination of Four Anthocyanins in Human Plasma after Black Currant Anthocyanins Ingestion
- 27 January 2010
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 58 (2) , 1174-1179
Development and Validation of a Liquid Chromatography Tandem Mass Spectrometry Method for Simultaneous Determination of Four Anthocyanins in Human Plasma after Black Currant Anthocyanins Ingestion
- Open Access
- 1 January 2002
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 89 (1) , 29-35
Endothelium-Dependent Vasorelaxation Induced by Black Currant Concentrate in Rat Thoracic Aorta
We investigated the effect of black currant (BC) concentrate on smooth muscle in rat thoracic aorta. BC concentrate dose-dependently relaxed the norepinephrine (0.1 μM)-precontracted aorta, and the response was abolished after endothelium removal. Both oxyhemoglobin (1 μM), a nitric oxide (NO) scavenger, and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ, 0.5 μM), an inhibitor of guanylyl cyclase (GC), inhibited the relaxing effect of BC concentrate. NG-nitro- L -arginine methyl ester ( L -NAME, 10 μM), a nitric oxide synthase (NOS) inhibitor, inhibited the relaxation, and the subsequent addition of L -arginine (1 mM), a NOS substrate, reversed the inhibitory effects of L -NAME. Neither indomethacin (10 μM), an inhibitor of cyclooxygenase, nor atropine (1 μM), an antagonist of muscarinic receptors, modified the effect of BC concentrate. Diphenhydramine (3 μM) and chlorpheniramine (2 μM), selective antagonists of H1-receptors, inhibited the relaxation, but cimetidine (0.3 mM), a selective antagonist of H2-receptors, did not affect the relaxation. These results indicate that, in the rat aorta, BC concentrate enhances synthesis of NO, which subsequently induces the endothelium-dependent vasorelaxation via the H1-receptors on the endothelium.
- 1 January 2002
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 89 (1) , 29-35
Open AccessEndothelium-Dependent Vasorelaxation Induced by Black Currant Concentrate in Rat Thoracic Aorta
We investigated the effect of black currant (BC) concentrate on smooth muscle in rat thoracic aorta. BC concentrate dose-dependently relaxed the norepinephrine (0.1 μM)-precontracted aorta, and the response was abolished after endothelium removal. Both oxyhemoglobin (1 μM), a nitric oxide (NO) scavenger, and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ, 0.5 μM), an inhibitor of guanylyl cyclase (GC), inhibited the relaxing effect of BC concentrate. NG-nitro- L -arginine methyl ester ( L -NAME, 10 μM), a nitric oxide synthase (NOS) inhibitor, inhibited the relaxation, and the subsequent addition of L -arginine (1 mM), a NOS substrate, reversed the inhibitory effects of L -NAME. Neither indomethacin (10 μM), an inhibitor of cyclooxygenase, nor atropine (1 μM), an antagonist of muscarinic receptors, modified the effect of BC concentrate. Diphenhydramine (3 μM) and chlorpheniramine (2 μM), selective antagonists of H1-receptors, inhibited the relaxation, but cimetidine (0.3 mM), a selective antagonist of H2-receptors, did not affect the relaxation. These results indicate that, in the rat aorta, BC concentrate enhances synthesis of NO, which subsequently induces the endothelium-dependent vasorelaxation via the H1-receptors on the endothelium.